Open to opportunities

Ann Peets

@annpeets

Message

AI-forward life sciences marketing leader driving portfolio growth and team excellence.

United States

Message

What I'm looking for

I’m looking for a marketing leadership role where I can lead AI-forward, omnichannel strategy, unify teams across global portfolios, and drive measurable growth. I thrive in organizations that value execution excellence and cross-functional partnership with sales and stakeholders.

I’m a transformational Life Sciences Marketing Vice President who blends traditional and AI marketing to accelerate growth and lead strong teams across complex product portfolios—from Pharmaceutical and Medical device to OTC and Consumer Healthcare.

I’m known for distilling insights into sustainable growth strategies that maximize market share and revenue growth across launch, turnaround, growth, and mature stages. From disciplined brand management to omnichannel campaign execution, I focus on building cohesive go-to-market plans that translate into measurable performance.

Across roles as Global Vice President of Marketing, Vice President of Marketing (Global Medical Devices), Head of Marketing, Marketing Director, and Product leadership, I’ve unified teams and portfolios, launched new business planning processes, and driven brand expansions. Whether transforming Paragard IUD growth, launching BD Rx and BD Simplist, or delivering EpiPen and respiratory franchise performance, my approach is consistent: strategy + execution with excellence, powered by AI-forward thinking and leadership that inspires results.

Experience

Work history, roles, and key accomplishments

Current

Marketing Vice President

Current

Insight Marketing, LLC

Jan 2022 - Present (4 years 3 months)

Transformed strategic plans into stronger, more consistent growth-focused marketing programs across multiple companies.

Strategic Planning Brand Development Marketing Execution Market Research Sales Partnerships Team Leadership

Global VP of Marketing

Safeguard Medical

Jan 2021 - Jan 2022 (1 year)

Unified six global life-saving product companies into a cohesive commercial market presence, improving customer experience. Assessed a 1,000-product portfolio to build a market-leading offering and developed the inaugural strategic plan to accelerate expansion.

Product Portfolio Management Strategic Planning Training Enablement Market Research Change Management Stakeholder Management

VP of Marketing, Global Devices

Coopersurgical, Inc.

Jan 2018 - Jan 2021 (3 years)

Built a winning, insights-driven marketing model for a 600-product medical device portfolio and Paragard IUD ($1B acquisition), partnering closely with sales to drive predictable, profitable growth. Repositioned Paragard from stagnation to 11% growth and increased consumer brand awareness from 3% to 96%, driving +6% brand awareness, +9% consideration, +6% HCP discussions, and +11% demand-driven sa

Strategic Marketing Product Portfolio Management Omnichannel Strategy Go To Market Planning Team Leadership Cross Functional Collaboration

Head of Marketing (Women's Health)

Afaxys, Inc.

Jan 2014 - Jan 2017 (3 years)

Led branding initiatives and marketing strategy across women’s health and GPO divisions, growing unit sales by 78% and launching five contraceptive products. Captured 40% market share and positioned Afaxys as a category leader, including #1 placement in 3 of 5 categories.

Brand and Product Positioning Product Launches Strategic Planning Market Research Agency Management Team Leadership Executive Reporting

Marketing Director, Prefilled Injectables

Becton Dickinson and Company (BD Rx, Inc.)

Jan 2011 - Jan 2014 (3 years)

Launched and drove commercialization of the BD Simplist line of ready-to-use prefilled injectables and established BD Rx, Inc. as the company’s first pharmaceutical division. Increased awareness by 30% and delivered strong early growth by leading 360° market analyses and integrated digital/PR/sales go-to-market planning.

Product Launch Market Analysis Integrated Marketing Go To Market Strategy Brand Management Revenue Growth

Group Marketing Director (EpiPen/Emsam)

Dey, A Mylan Company

Jan 2009 - Jan 2010 (1 year)

Drove 10% growth for EpiPen by leading cross-functional execution of consumer and HCP-focused marketing plans and strengthening brand messaging. Repositioned anaphylaxis as “allergic emergency,” increased sales by 12% per airing, launched the company’s first national integrated DTC plan in 24 years, and contributed to competitor exits.

Brand Messaging HCP Marketing Cross Functional Execution